focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLAN.L Regulatory News (GLAN)

  • There is currently no data for GLAN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Octopus Investments - Glantus Holdings plc

1 Aug 2023 15:32

Form 8.3 - Octopus Investments - Glantus Holdings plc

Ap19

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)OCTOPUS INVESTMENTS LTD
Company dealt inGlantus Holdings plc
Class of relevant security to which the dealings being disclosed relate (Note 2)Ordinary Shs EUR 0.001
Date of dealing31/07/2023
INTERESTS AND SHORT POSITIONS Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 LongShort
 Number (%)Number (%)
(1) Relevant securities1,916,176 (3.75%) 
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total1,916,176 (3.75%) 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
 Number (%)Number (%)
(1) Relevant securities  
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total  

 

Ap20

 

DEALINGS (Note 4) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
Sale135,000£0.203333
Sale90,000£0.203333

 

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFDNature of transaction (Note 6)Number of relevant securities (Note 7)Price per unit (Note 5)
    

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

Product name, e.g. call optionWriting, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
       

 

(ii) Exercising

Product name, e.g. call optionNumber of securitiesExercise price per unit (Note 5)
   

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)DetailsPrice per unit (if applicable) (Note 5)
   

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9) YES/NO

Date of disclosure01/08/2023
Contact nameRobbie Campbell
Telephone number020 3142 4726
If a connected EFM, name of offeree/offeror with which connected 
If a connected EFM, state nature of connection (Note 10) 

 

Date   Source Headline
28th Jul 20227:00 amRNSCustomer Win
22nd Jul 20225:44 pmRNSDebt refinancing successfully completed
5th Jul 20227:00 amRNSCustomer Win - Bunzl plc
29th Jun 20227:00 amRNSAnnual Report and AGM Notice
20th Jun 20227:00 amRNSCompletion of Nominated Advisor due diligence
13th Jun 20224:12 pmRNSNotification of Major Holdings
30th May 20227:00 amRNSYear End Results
27th May 20227:05 amRNSNotification of Investor Presentation
27th May 20227:00 amRNSNotification of Year End Results Announcement
27th Apr 20227:05 amRNSChange of Registered Address
27th Apr 20227:00 amRNSChange of Nominated Adviser and Broker
25th Apr 202212:28 pmRNSNotification of Major Holdings
21st Apr 202211:20 amRNSNotification of Investor Webinar
5th Apr 20227:00 amRNSAnnouncement of TealBook Partnership
2nd Mar 20227:00 amRNSAppointment of Chief Corporate Growth Officer
25th Feb 20227:00 amRNSAppointment of Chief Operating Officer
13th Dec 20217:00 amRNSLaunch of New Global Partnership Program
24th Nov 20217:00 amRNSAcquisition of Meridian Cost Benefit Limited
6th Oct 20217:00 amRNSGlantus and VAT IT UK Ltd Announce Partnership
29th Sep 20217:01 amRNSNotice of Investor Presentation
29th Sep 20217:00 amRNSMaiden Interim Results
27th Sep 20213:40 pmRNSNotification of Major Holdings
21st Sep 20217:00 amRNSNotification of Interim Results
29th Jul 20217:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20217:00 amRNSDirector/PDMR Shareholding
27th Jul 20216:08 pmRNSReplacement - Acquisition of Technology Insight
26th Jul 20213:32 pmRNSHolding(s) in Company
19th Jul 20217:00 amRNSPURCHASE OF SHARES BY DIRECTOR
16th Jul 20217:00 amRNSAcquisition of Technology Insight Corporation
1st Jul 20217:00 amRNSNotification of Investor Presentation
23rd Jun 20217:00 amRNSNotification of Major Shareholding
17th May 20217:00 amRNSNotice of Investor Presentation
13th May 20214:34 pmRNSHolding(s) in Company
13th May 20214:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.